公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Rapid detection of biofilm with modified alcian blue staining: In-vitro protocol improvement and validation with clinical cases | Wu Y.-F.; Lee T.-Y.; Liao W.-T.; Chuan H.-H.; NAI-CHEN CHENG ; Cheng C.-M. | Wound Repair and Regeneration | 11 | 9 | |
2008 | Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells | JEN-CHUNG KO ; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W. | Molecular Cancer Therapeutics | 38 | 35 | |
2009 | Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells | JEN-CHUNG KO ; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W. | Molecular Cancer Research | 45 | 40 | |
2010 | Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells | JEN-CHUNG KO ; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W. | Biochemical Pharmacology | 71 | 62 | |
2011 | A systematized FMEA practice for magnet relays | Cheng C.-M.; Wu W.-F. ; Hsu Y. | Advanced Materials Research | 0 | 0 | |
2021 | Transdermal drug delivery systems for fighting common viral infectious diseases | Wang F.-Y; Chen Y; Huang Y.-Y; Cheng C.-M.; YI-YOU HUANG | Drug Delivery and Translational Research | |||
2013 | Using surfaces to modulate the morphology and structure of attached cells-a case of cancer cells on chitosan membranes | Shuai H.-H.; Yang C.-Y.; Harn H.I.-C.; York R.L.; Liao T.-C.; WEN-SHIANG CHEN ; Yeh J.A.; Cheng C.-M. | Chemical Science | 30 | 29 |